Blue Diamond Ventures Inc (BLDV)

[JPS02]

Explore Israel's Medical Cannabis Research With iCan

Published on Mar 31, 2016

As Israel continues to take the lead in medical marijuana research, we can only wonder what the future holds. What kind of Israeli cannabis products can the world expect? Saul Kaye is the CEO of iCan, an Israeli company bringing cannabis products to the global market; and he's here in our ILTV studio with more. www.ILTV.tv israel-cannabis.com/

Key takeaways from the YouTube clip above that are relevant to BLDV and help explain why BLDV is going to Israel:

1. U.S. firms turn to Israel for cannabis research and development

2. Israel is an industry leader because of its highly developed agriculture technology and liberal approach to marijuana studies (i.e. plant sciences)

3. Cannabis is promising but difficult and complicated > implying that good quality seeds and technology are important

4. Since 2014, U.S. companies have invested $50 million in licensing Israeli medical marijuana devices

5. Cannatech 2017 - BLDV attended this conference as mentioned in BLDV's 4/20 PR and on FB:

https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures--Inc--launches-International-Cannabis-Project-with-AMS-Canada?id=156512&b=y

https://www.facebook.com/108751362804882/photos/a.108785682801450.1073741827.108751362804882/411598989186783/?type=3&theater

Here are the highlights from Cannatech 2017:

Go BLDV!